One insider scooped up many shares as Carl Icahn exited his stake in a medical device maker. There were other notable insider purchases too.

Unsuccessful short-selling has reportedly put billionaire Carl Icahn's private hedge fund into a six-year-long red streak.

Carl Icahn's son and a portfolio manager for Icahn Capital resigned from the board of Bausch + Lomb after Paulson Capital bought out Icahn Group's shares of its parent company. Brett Icahn and Gary Hu ...

(Reuters) -Contact lens maker Bausch + Lomb said on Monday Brett Icahn and Gary Hu have resigned from its board of directors after the termination of the agreement with billionaire investor Carl Icahn ...

Billionaire activist investor Carl Icahn exited stakes in Dana Inc. (NYSE:DAN) and Illumina (NASDAQ:ILMN) in Q2, according to ...

The Trump administration is casting a wide net, scouring other companies that it thinks could be ripe for some form of ...

NASHVILLE, Tenn. (WKRN) — A scrapyard along the Cumberland River in downtown Nashville has officially been sold. The 45-acre ...

The latest East Bank transaction is the equivalent of about $5.44 million per acre, with both the acreage and per-acre ...

Icahn's reportable stock portfolio totaled nearly $28 billion in value as of September 30, 2015. Its top two holdings, Icahn Enterprises L.P. and Apple, made up 48% of the overall portfolio's value.

The president is demanding government stakes in U.S. companies and cuts of their revenue. Experts see some similarities to ...